Cardiac Rhythm Management Devices | Market Insights | Europe (Supplemental) | 2022
Although the COVID-19 pandemic had a negative impact on procedure volumes and market growth in 2020, the European CRM device market will grow modestly over the forecast period. Increasing competition in the leadless pacemaker and S-ICD markets will result in falling prices and the availability of devices with improved quality. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues. The emergence of smart modules for cardiac monitoring will bolster the ICM market.
This Medtech 360 Report provides high-level market metrics for CRM devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across an 11-year period.
